Senseonics Holdings, Inc. announced a strategic partnership with Rimidi, a leading clinical management platform designed to optimize clinical workflows, enhance patient experiences, and achieve quality objectives for chronic disease management, in the development of its Eversense® Remote Patient Monitoring (RPM) Program for use by the health care providers. The partnership will integrate Eversense glucose data into Rimidi's comprehensive clinical management platform used by health systems, capitated health plans and physician practices. Rimidi's platform aligns with Medicare?s reimbursable remote patient monitoring telehealth programs while seamlessly integrating within existing Electronic Health Record (EHR) systems, supporting quality improvement initiatives, driving workflow optimization, increasing patient engagement and providing clinical decision support.

Powered by Rimidi, the Eversense CGM + RPM solution is intended to seamlessly and securely push patient glucose data to the most widely used EHR systems, to provide direct access for healthcare providers. With increased visibility on glucose trends, high or low event frequency, and time-in-range statistics, providers will be able to proactively engage patients to provide lifestyle and therapy optimization guidance in order to better manage their diabetes, lower healthcare costs and improve clinical outcomes.